I fully well understand the ramifications. And my post was more geared towards adjunct recruitment. But even so, the results are no less impressive than the previous Hep C meds.
And frankly, I don't think you know who you're talking to insinuate I don't know what I'm talking about. But I take no offense. I'm deeply involved with various physicians involved in many different clinical trials for a variety of indications. Although I do not have HIV, I have dealt with my own medical issues to know what a big decision it can be. But to suggest that skepticism is the reason is greater than I think it is made to be.
News 
Market Data 
Discover 
AI
